PNC Financial Services Group
ITRM

PNC Financial Services Group’s Iterum Therapeutics ITRM Stock Holding History

PNC Financial Services Group’s Portfolio ITRM Stock Details ITRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-445
Closed -$374 – 4757
2022
Q4 		$374 Buy
445
+12
+3% +$17 ﹤0.01% 4570
2022
Q3 		$1K Hold
433
– – ﹤0.01% 4324
2022
Q2 		$1K Hold
433
– – ﹤0.01% 4348
2022
Q1 		$2K Hold
433
– – ﹤0.01% 4199
2021
Q4 		$3K Hold
433
– – ﹤0.01% 4075
2021
Q3 		$4K Hold
433
– – ﹤0.01% 3990
2021
Q2 		$15K Buy
+433
New +$9.39K ﹤0.01% 3573

Other funds holding ITRM

NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
KF
Krilogy Financial St. Louis, Missouri $3.38B AUM 30.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
FWM
Focused Wealth Management Newburgh, New York $964M AUM 18.71% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
KFS
Kelly Financial Services Braintree, Massachusetts $467M AUM 21.13% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

PNC Financial Services Group's ITRM Position: Q1 2023 in Review

PNC Financial Services Group sold out of Iterum Therapeutics (ITRM) in Q1 2023, closing a stake of 445 shares — an estimated $374 sold.

PNC Financial Services Group first reported a position in ITRM in Q2 2021 and held it in 7 quarters. The position peaked at $15K in Q2 2021. 17 funds tracked by Wall St. Rank hold ITRM as of Q1 2023.

  • PNC Financial Services Group reported no remaining Iterum Therapeutics position as of Q1 2023 after selling out during the quarter.
  • PNC Financial Services Group sold 445 Iterum Therapeutics shares in Q1 2023, an estimated $374.
  • PNC Financial Services Group first reported a position in Iterum Therapeutics in Q2 2021 and held it in 7 quarters.
  • PNC Financial Services Group's Iterum Therapeutics position peaked at $15K in Q2 2021.
  • 17 funds tracked by Wall St. Rank held Iterum Therapeutics as of Q1 2023.

Based on PNC Financial Services Group's 13F filing for Q1 2023, filed 15 May 2023.